Peptides 31:15041510 Chen L, Cohen J, Song X, Zhao A, Ye Z, Feulner CJ, Doonan P, Somers W, Lin L et al (2016) Improved variants of SrtA for site-specific conjugation on antibodies and proteins with high efficiency
Cagrilintide monotherapy for treatment of obesity In a 26-week phase 2 trial (n=706, 62 Percentage women, mean age 52 years), cagrilintide was evaluated in 5 groups of subjects receiving 0.3, 0.6, 1.2, 2.4, and 4.5 mg/week as treatment for obesity in comparison with liraglutide 3.0 mg/day, and placebo (table 1) [9]
415,416 IF is an effective strategy for controlling weight and increasing insulin sensitivity in patients with diabetes and can also improve cardiometabolic outcomes
Indian J Pharmaceut Educ Res 51:626635 Alhat BR, Kokate SV (2019) method development and validation for simultaneous estimation of l-glutathione and Vitamin-C in effervescent tablet by RP-HPLC